TITLE

Review: B-type natriuretic peptide consistently predicts death and cardiovascular events in heart failure

AUTHOR(S)
Deswal, Anita
PUB. DATE
September 2005
SOURCE
ACP Journal Club;Sep/Oct2005, Vol. 143 Issue 2, p53
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study on how well does B-type natriuretic peptide (BNP) predict mortality and morbidity. Studies in any language were selected if they evaluated the prognostic value of BNP in patients with heart failure. Nineteen studies assessed the relation between BNP levels and death or cardiovascular events in patients with heart failure. The studies were done in various clinical settings and used various BNP tests. The inclusion of the fifth study led to statistically significant heterogeneity. Seven studies used dichotomous measures to assess the relation between BNP and death.
ACCESSION #
18427124

 

Related Articles

  • Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Houweling, Arjan C.; van Borren, Marcel M.; Moorman, Antoon F.M.; Christoffels, Vincent M. // Cardiovascular Research;Sep2005, Vol. 67 Issue 4, p583 

    Abstract: The endocrine function of the heart was shown by the identification of a potent inhibitor of renal tubular NaCl reabsorbtion, atrial natriuretic peptide/factor (ANP), in atrial extracts. Since then, Nppa, the gene encoding ANP, has become an important tool for molecular and...

  • Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin I and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund, E.; Jernberg, T.; Johanson, P.; Venge, P.; Dellborg, M.; L. Wallentin; Lindahl, B. // Heart;Jun2006, Vol. 92 Issue 6, p735 

    Objective: To assess the long term prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP) on admission and its prognostic interaction with both admission troponin T (TnT) concentrations and resolution of ST segment elevation in fibrinolytic treated ST elevation myocardial...

  • The heart as an endocrine organ. Sagnella, Guiseppe A. // Biologist;Dec2002, Vol. 49 Issue 6, p275 

    Discusses the role of the heart in the control of body sodium, an important determinant of the extracellular fluid volume and thereby of total blood volume. Details on the discovery of atrial natriuretic peptide in the heart; Importance of atrial natriuretic peptide as a natriuretic factor;...

  • No difference in N-terminal pro-brain natriuretic peptide (NF-proBNP) concentrations between endurance athletes with athlete's heart and healthy untrained controls. Scharhag, J.; Urhausen, A.; Herrmann, M.; Schneider, G.; Kramann, B.; Herrmann, W.; Kindermann, W. // Heart;Sep2004, Vol. 90 Issue 9, p1055 

    It is assumed that the athlete's heart represents a physiological adaptation to endurance exercise, caused by an increased volume load.' As a new cardiac biomarker, brain natriuretic peptide allows to serologically perceive inyocardial wall stress. In contrast to atrial natriuretic peptide,...

  • Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Gavin, A. D.; Struthers, A. D. // Heart;Jun2005, Vol. 91 Issue 6, p749 

    Objective: To study whether the effect of allopurinol on improvement of endothelial dysfunction in chronic heart failure (CHF) translates into improved exercise capacity and to examine whether allopurinol also improves B-type natriuretic peptide (BNP), the other important prognostic marker of...

  • ROLE B-TYPE NATRIURETIC PEPTIDE (BNP) AND NOT-PROBNP IN CLINICAL ROUTINE. Weber, Michael; Hamm, Christian // Heart;Jun2006, Vol. 92 Issue 6, p843 

    In recent years biomarkers have emerged as important tools for diagnosis, risk stratification and therapeutic decision making in cardiovascular diseases. Cardiac troponins in particular have become the cornerstone for diagnostic work up of patients with acute coronary syndromes. Currently,...

  • Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Hensen, Johannes; Abraham, William T.; Lesnefsky, Edward J.; Levenson, Benny; Groves, Bertron M.; Schröder, Klaus; Schrier, Robert W.; Dürr, Jacques // Kidney International;May1992, Vol. 41 Issue 5, p1333 

    Three studies were performed: (1) a controlled investigation of α-human atrial natriuretic pepltide (α-hANP) lolal body production and metabolic clearance rates using a bolus infusion technique (controls, patients 1 to 6); (2) a study of α-hANP kinetics in cardiac dysfunction patients...

  • B-type natriuretic peptide as heart failure indicator.  // Nursing Standard;4/20/2005, Vol. 19 Issue 32, p18 

    Discusses B-type natriuretic peptide (BNP) as a prognostic indicator for patient with heart failure. Release of the peptide by the heart in response to myocardial tension and increased intravascular volume; Clinical assessment of prognosis in heart failure; Review of studies that estimated the...

  • B-type natriuretic peptide in patients with congenital heart disease.  // Cardiology in the Young;May2005 Supplement 2, Vol. 15 Issue S2, p12 

    The article presents a study to evaluate the impact of plasma B-type natriuretic peptide (BNP) on patients with congenital heart defects. BNP is a cardiac hormone secreted mainly by the ventricles with diuretic, natriuretic, and vasodilatory properties. Plasma BNP correlates well with systolic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics